Summary
Caltech researchers have developed BrainCAB, a novel small-molecule delivery system that helps medicines cross the blood-brain barrier, showing promise in preclinical trials for delivering therapeutic cargo. This platform could potentially deliver antibodies, proteins, and RNA medicines, though human trials are still needed.